| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 458.74 | 91 |
| GSM780708 | Untreated after 4 days (C2_1) | 395.577 | 90 |
| GSM780709 | Untreated after 4 days (C3_1) | 357.751 | 89 |
| GSM780719 | Untreated after 4 days (C1_2) | 548.57 | 92 |
| GSM780720 | Untreated after 4 days (C2_2) | 458.963 | 91 |
| GSM780721 | Untreated after 4 days (C3_2) | 384.99 | 90 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 367.942 | 89 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 505.968 | 92 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 522.196 | 92 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 375.529 | 89 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 492.481 | 91 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 511.114 | 92 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 477.591 | 91 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 421.198 | 90 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 463.557 | 91 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 548.57 | 92 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 428.927 | 90 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 492.298 | 91 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 551.536 | 92 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 500.791 | 92 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 477.743 | 91 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 465.155 | 91 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 409.554 | 90 |